NF-ΚB signaling dynamics play a key role in infection control in tuberculosis

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Fallahi Sichani, Mohammad ^a,c   Kirschner, Denise E ^b   Linderman, Jennifer J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Granuloma; Multi scale modeling; NF B signaling pathway; Systems biology; Tuberculosis; tumor necrosis factor

Indexed keywords

EID: 84866354551     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00170     Document Type: Article

References (62)

1. Albeck, J. G., Burke, J. M., Spencer, S. L., Lauffenburger, D. A., and Sorger, P. K. (2008). Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 6, 2831-2852. doi:10.1371/journal.pbio.0060299
2. Algood, H. M., Chan, J., and Flynn, J. L. (2003). Chemokines and tuberculosis. Cytokine Growth Factor Rev. 14, 467-477.
3. Algood, H. M., Lin, P. L., Yankura, D., Jones, A., Chan, J., and Flynn, J. L. (2004). TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J. Immunol. 172, 6846-6857.
4. Baltimore, D. (2011). NF-kappaB is 25. Nat. Immunol. 12, 683-685.
5. Barry, C. E.,3rd, Boshoff, H. I., Dar-tois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., and Young, D. (2009). The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7, 845-855.
6. Basak, S., and Hoffmann, A. (2008). Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev. 19, 187-197.
7. Bean, A. G., Roach, D. R., Briscoe, H., France, M. P., Korner, H., Sedgwick, J. D., and Britton, W. J. (1999). Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162, 3504-3511.
8. Beg, A. A., and Baltimore, D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784.
9. Blower, S. M., and Dowlatabadi, H. (1994). Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62, 229-243.
10. Chakravarty, S. D., Zhu, G., Tsai, M. C., Mohan, V. P., Marino, S., Kirschner, D. E., Huang, L., Flynn, J., and Chan, J. (2008). Tumor necrosis factor blockade in chronic murine tuberculosis enhances granuloma-tous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76, 916-926.
11. Cheong, R., Bergmann, A., Werner, S. L., Regal, J., Hoffmann, A., and Levchenko, A. (2006). Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. J. Biol. Chem. 281,2945-2950.
12. Cheong, R., Hoffmann, A., and Levchenko, A. (2008). Understanding NF-kappaB signaling via mathematical modeling. Mol. Syst. Biol. 4,192.
13. Clay, H., Volkman, H. E., and Ramakrishnan, L. (2008). Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29, 283-294.
14. Cooper, A. M. (2009). Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422.
15. Davis, J. M., and Ramakrishnan, L. (2008). "The very pulse of the machine": the tuberculous granuloma in motion. Immunity 28, 146-148.
16. Fallahi-Sichani, M., El-Kebir, M., Marino, S., Kirschner, D. E., and Linderman, J. J. (2011). Multiscale computational modeling reveals a critical role for TNF-{alpha} receptor 1 dynamics in tuberculosis granuloma formation. J. Immunol. 186, 3472-3483.
17. Fallahi-Sichani, M., Flynn, J. L., Linderman, J. J., and Kirschner, D. E. (2012). Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability. J. Immunol. 188,3169-3178.
18. Fallahi-Sichani, M., Schaller, M. A., Kirschner, D. E., Kunkel, S. L., and Linderman, J. J. (2010). Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma. PLoS Comput. Biol. 6, e1000778. doi:10.1371/journal.pcbi.1000778
19. Flynn, J. L. (2004). Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84, 93-101.
20. Flynn, J. L., Chan, J., and Lin, P. L. (2011). Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol. 4, 271-278.
21. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowen-stein, C. J., Schreiber, R., Mak, T. W., and Bloom, B. R. (1995). Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572.
22. Flynn, J. L., and Klein, E. (2010). "Pulmonary tuberculosis in monkeys," in A Color Atlas of Comparative Pulmonary Tuberculosis Histopathol-ogy, eds. J. Leong, V. Dartois, and T. Dick (Boca Raton: CRC Press, Taylor & Francis Publishers), 83-106.
23. Fotin-Mleczek, M., Henkler, F., Samel, D., Reichwein, M., Hausser, A., Parmryd, I., Scheurich, P., Schmid, J. A., andWajant, H. (2002). Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell.Sci. 115,2757-2770.
24. Gutierrez, M. G., Mishra, B. B., Jor-dao, L., Elliott, E., Anes, E., and Griffiths, G. (2008). NF-kappa B activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J. Immunol. 181,2651-2663.
25. Hao, S., and Baltimore, D. (2009). The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol. 10,281-288.
26. Harris, J., Hope, J. C., and Keane, J. (2008). Tumor necrosis factor block-ers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198,1842-1850.
27. Hayden, M. S., and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.
28. Hoffmann, A., and Baltimore, D. (2006). Circuitry of nuclear factor kap-paB signaling. Immunol. Rev. 210, 171-186.
29. Hoffmann, A., Levchenko, A., Scott, M. L., and Baltimore, D. (2002). The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241-1245.
30. Karin, M., and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
31. Keane, J., Balcewicz-Sablinska, M. K., Remold, H. G., Chupp, G. L., Meek, B. B., Fenton, M. J., and Kornfeld, H. (1997). Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65, 298-304.
32. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., and Braun, M. M. (2001). Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345, 1098-1104.
33. Keane, J., Shurtleff, B., and Kornfeld, H. (2002). TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) 82, 55-61.
34. Kearns, J. D., and Hoffmann, A. (2009). Integrating computational and biochemical studies to explore mechanisms in NF-{kappa}B signaling. J. Biol. Chem. 284, 5439-5443.
35. Kirschner, D. E., Young, D., and Flynn, J. L. (2010). Tuberculosis: global approaches to a global disease. Curr. Opin. Biotechnol. 21, 524-531.
36. Lin, P. L., and Flynn, J. L. (2010). Understanding latent tuberculosis: a moving target. J. Immunol. 185, 15-22.
37. Lin, P. L., Myers, A., Smith, L., Big-bee, C., Bigbee, M., Fuhrman, C., Grieser, H., Chiosea, I., Voitenek, N. N., Capuano, S. V., Klein, E., and Flynn, J. L. (2010). Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal gran-uloma structure in a cynomolgus macaque model. Arthritis Rheum. 62,340-350.
38. Lin, P. L., Pawar, S., Myers, A., Pegu, A., Fuhrman, C., Reinhart, T. A., Capuano, S. V., Klein, E., and Flynn, J. L. (2006). Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect. Immun. 74, 3790-3803.
39. Lin, P. L., Plessner, H. L., Voitenok, N. N., and Flynn, J. L. (2007). Tumor necrosis factor and tuberculosis. J. Investig. Dermatol. Symp. Proc. 12, 22-25.
40. Lipniacki, T., Puszynski, K., Paszek, P., Brasier, A. R., and Kimmel, M. (2007). Single TNFalpha trimers mediating NF-kappaB activation: stochastic robustness of NF-kappaB signaling. BMC Bioinformatics 8, 376. doi:10.1186/1471-2105-8-376
41. Marino, S., El-Kebir, M., and Kirschner, D. (2011). A hybrid multi-compartment model of granuloma formation and T cell priming in Tuberculosis. J. Theor. Biol. 280, 50-62.
42. Marino, S., Fallahi-Sichani, M., Lin-derman, J. J., and Kirschner, D. E. (2012). "Mathematical Models of Anti-TNF Therapies and their Correlation with Tuberculosis," in Antibody-Mediated Drug Delivery Systems: Concepts, Technology and Applications, eds. Y. Pathak and S. Benita (Hoboken, NJ: John Wiley & Sons, Inc.), 83-104.
43. Marino, S., Hogue, I. B., Ray, C. J., and Kirschner, D. E. (2008). A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254, 178-196.
44. Marino, S., Sud, D., Plessner, H., Lin, P. L., Chan, J., Flynn, J. L., and Kirschner, D. E. (2007). Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavail-ability in granulomatous tissue. PLoS Comput. Biol. 3, 1909-1924. doi:10.1371/journal.pcbi.0030194
45. Morel, P. A., Ta'asan, S., Morel, B. F., Kirschner, D. E., and Flynn, J. L. (2006). New insights into mathematical modeling of the immune system. Immunol. Res. 36, 157-165.
46. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
47. Nelson, D. E., Ihekwaba, A. E., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., Nelson, G., See, V, Horton, C. A., Spiller, D. G., Edwards, S. W., McDowell, H. P., Unitt, J. F., Sullivan, E., Grim-ley, R., Benson, N., Broomhead, D., Kell, D. B., and White, M. R. (2004). Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306, 704-708.
48. Pahl, H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
49. Rangamani, P., and Sirovich, L. (2007). Survival and apoptotic pathways initiated by TNF-alpha: modeling and predictions. Biotechnol. Bioeng. 97, 1216-1229.
50. Ray, J. C., Flynn, J. L., and Kirschner, D. E. (2009). Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182, 3706-3717.
51. Roach, D. R., Bean, A. G., Demangel, C., France, M. P., Briscoe, H., and Britton, W J. (2002). TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobac-terial infection. J. Immunol. 168, 4620-4627.
52. Russell, D. G., Barry, C. E. III, and Flynn, J. L. (2010). Tuberculosis: what we don't know can, and does, hurt us. Science 328, 852-856.
53. Segovia-Juarez, J. L., Ganguli, S., and Kirschner, D. (2004). Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model.J. Theor. Biol. 231, 357-376.
54. Tay, S., Hughey, J. J., Lee, T. K., Lipniacki, T., Quake, S. R., and Covert, M.W (2010). Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature 466, 267-271.
55. Tsai, M. C., Chakravarty, S., Zhu, G., Xu, J., Tanaka, K., Koch, C., Tufariello, J., Flynn, J., and Chan, J. (2006). Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell. Microbiol. 8,218-232.
56. Turner, O.C., Basaraba, R. J., Frank, A. A., and Orme, I. M. (2003). "Granuloma formation in mouse and guinea pig models of experimental tuberculosis," in Granulomatous Infections and Inflammations: Cellular and Molecular Mechanisms, ed. D. L. Boros (Washington, DC: ASM Press), 65-84.
57. Ulrichs, T., Kosmiadi, G. A., Trusov, V., Jorg, S., Pradl, L., Titukhina, M., Mishenko, V., Gushina, N., and Kauf-mann, S. H. (2004). Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204, 217-228.
58. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
59. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., Ma, A., Koonin, E. V., and Dixit, V. M. (2004). De-ubiquitination and ubiquitin lig-ase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699.
60. Winthrop, K. L. (2006). Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat. Clin. Pract. Rheumatol. 2, 602-610.
61. Yamada, H., Mizuno, S., Reza-Gholizadeh, M., and Sugawara, I. (2001). Relative importance of NF-kappaB p50 in mycobacter-ial infection. Infect. Immun. 69, 7100-7105.
62. Yde, P., Mengel, B., Jensen, M. H., Krishna, S., and Trusina, A. (2011). Modeling the NF-kappaB mediated inflammatory response predicts cytokine waves in tissue. BMC Syst. Biol. 5,115-123.